Why the Mach7 (ASX:M7T) share price is lifting today

The Mach7 Technologies Ltd (ASX: M7T) share price is up 2% today following a positive update on its flagship project.

| More on:
three building blocks with smiley faces, indicating a rise in the ASX share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Mach7 Technologies Ltd (ASX: M7T) share price is edging higher in mid-afternoon trade. This comes after the company provided an update on its project with the Hong Kong Hospital Authority (HAHK).

At the time of writing, shares in the enterprise imaging platform provider are up 2.06% to $1.48.

Additional sales opportunities

The Mach7 share price is lifting higher after reporting progress on its flagship project.

In today's release, Mach7 advised it had received $4.2 million in sales orders in the current financial year. The purchases include a licenced volume order for the company's Vendor Neutral Archive (VNA), worth close to $3 million.

Mach7 highlighted that the recent sales orders were based on the original contract with HAHK, signed in October 2018. The deal involved Mach7 delivering its enterprise imaging solution (EIS) to HAHK, which was valued at $15 million. So far, $10 million worth of orders have been provided.

The EIS platform allows images to be securely shared across private and public healthcare providers. This relates to the receiving, transfer, storage and viewing by authorised users.

Interestingly, HAHK is a government division that looks after the administration of Hong Kong's public hospitals. They include 43 public hospitals and institutions, 48 specialist outpatient clinics and 73 general outpatient clinics. Once Mach7's project is completed, it will serve the entire territory of Hong Kong with its EIS. It's expected that the platform will be fully deployed by June this year.

In addition, the company revealed that its successful rollout has led to additional sales opportunities with HAHK. Currently, it has received $1.8 million worth of purchase orders, including the use of Mach7's ophthalmology system.

CEO commentary

Commenting on the update, Mach7 CEO Mike Lampron said:

Throughout this project, the hospital authority's commitment to delivering the best possible care to its patients has been central to our approach in implementation and system design.

We're confident that once Mach7's Enterprise Imaging Solution is fully implemented; they will be able to deliver the quality of care their patients expect. We are proud to be working with the Hospital Authority of Hong Kong to deliver these enhancements to their processes so they may better serve the people of Hong Kong.

Mach7 share price performance

The Mach7 share price has tracked more than 60% higher in the past 12 months, reflecting stable growth.

The company's shares dropped to a 52-week low of 37 cents in last year's March market crash as COVID-19 impacts took hold, before tracking upwards. Just late last month, its shares reached a multi-year high of $1.59.

Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends MACH7 FPO. The Motley Fool Australia has recommended MACH7 FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Broker Notes

These ASX 200 shares could rise 50% to 60%

Brokers believe these shares could deliver big returns for investors.

Read more »

A girl is handed an oversized ice cream cone with lots of different flavours.
Best Shares

8 ASX All Ords shares that tripled in value in FY25

Just 8 out of the 500 companies making up the ASX All Ords achieved share price growth of 200% or…

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Woman with a scared look has hands on her face.
Broker Notes

Bapcor shares fell more than 30% yesterday. Should investors buy in the dip?

Is this a value opportunity?

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Broker Notes

Broker raises price targets on 2 ASX 200 shares to buy

Ord Minnett has just upped its 12-month share price targets on 2 buy-rated ASX 200 stocks.

Read more »

Man with rocket wings which have flames coming out of them.
Share Gainers

Guess which ASX All Ords stock just rocketed 34% on strong earnings growth

Investors just sent this ASX All Ords stock surging 34%. Here’s what’s happening.

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why DroneShield, Gentrack, Metals X, and Northern Star shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Gainers

Why Dimerix, Newmont, Regal Partners, and Titomic shares are storming higher

These shares are having a good finish to the week. Let's see why.

Read more »